1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ESTRELLA BIOPHARMA INC
Estrella Biopharma Inc
XNAS: ESLA
Download real time
0.65 0.01 (1.56%)
New 52W Low today
69,449
XNAS Volume
High volume today

XNAS 04 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Estrella Biopharma Inc

The latest disclosure was made by Cheng Liu in Estrella Biopharma Inc where a trade of 100,000 Common Stock, par value $0.0001 per share done at an average price of $0.8 was reported to US exchanges on Aug. 25, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Cheng Liu Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.82 per share. 25 Aug 2026 100,000 397,437 - 0.8 81,500 Common Stock, par value $0.0001 per share
Cheng Liu Director, CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Aug 2026 100,000 900,000 - - Incentive Stock Option
Jiandong Xu Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.82 per share. 18 Aug 2026 100,000 365,488 - 0.8 81,500 Common Stock, par value $0.0001 per share
Jiandong Xu Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2026 100,000 390,796 - - Incentive Share Option
Cheng Liu Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2024 490,796 490,796 - - Incentive Share Option
Cheng Liu Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2024 509,204 509,203 - - Nonstatutory Share Option
Jiandong Xu Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2024 490,796 490,796 - - Incentive Share Option
Jiandong Xu Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Oct 2024 509,204 509,203 - - Nonstatutory Share Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters